Retail drugstore chain operator Rite Aid Corp. reported Thursday a profit for the first quarter that more than halved from last year, despite improved margins and revenue growth, hurt by costs related to the EnvisionRx acquisition. Stripping down the costs, adjusted earnings per share topped analysts’ expectations by a penny, while quarterly revenues matched their estimates.